In this webinar, the development and performance of these designs will be discussed in-depth, as well as the effect of various choices made during the bait designing process. The unique breeding history of the dog that shaped the phenotypical diversity, also affects the identification of disease-causing mutations. While the advantage for GWAS was already demonstrated in 2007, we recently showed that this equally applies for direct sequencing approaches like WES.
Don't wait to register for the Development of Canine Exome Sequencing Methods to Identify Disease-causing Variants. You'll meet influential people and maximize your opportunities for success. Start now by accessing the information below.
|Conference/Event Dates:||04/07/2016 - 04/07/2016|
|Primary Industry:||Clinical Pharmacology|
|Other Industries:||Clinical Pharmacology, Genetics, Professional Healthcare, Veterinary Medicine / Animal Health|
|Audience:||Genetics and Genomics Researchers
Clinical and Translational Researchers
Genome Center Directors
R&D Directors, Managers in Pharmaceutical and Biotechnology Companies
Agricultural Genetic Researchers
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.